World’s First Human Implant of a 3D-Printed Cornea Restores Sight
December 15, 2025
Background
Workers and responders with high radiation exposure had numerous cases of HRIS. Risk of HRIS from intentional radioactive material releases requires prevention.
Higher doses above 1 Gy leads to increased severity of HRIS. Acute exposure occurs in HRIS compared to chronic exposure.
Children and older adults more at risk from radiation due to weaker immune systems. A lack of strong evidence shows gender differences in HRIS susceptibility, with potential radiation sensitivity variations.
Epidemiology
Workers and responders with high radiation exposure had numerous cases of HRIS. Risk of HRIS from intentional radioactive material releases requires prevention.Â
Higher doses above 1 Gy leads to increased severity of HRIS. Acute exposure occurs in HRIS compared to chronic exposure.Â
Children and older adults more at risk from radiation due to weaker immune systems. A lack of strong evidence shows gender differences in HRIS susceptibility, with potential radiation sensitivity variations.Â
Anatomy
Pathophysiology
Ionizing radiation causes DNA breaks in bone marrow stem and progenitor cells causes death and mutations.Â
Cells activate DNA damage response mechanisms cell cycle arrest, repair pathways, and apoptosis for irreparable damage.Â
Radiation affects hematopoietic stem cells proliferation and differentiation into blood cell lineages to reduce their function.Â
Growth factors such as G-CSF and erythropoietin stimulate hematopoietic stem cell proliferation and differentiation.Â
Etiology
Genetics
Prognostic Factors
High-dose exposure results in severe HRIS, that increases mortality risk.Â
Children and elder individuals at higher risk due to weak immunity.Â
Medical intervention with growth factors, blood transfusions, and antibiotics improves outcomes.Â
Specialized medical facilities and expertise manage radiation injuries for prognosis.Â
Higher functional bone marrow post-exposure leads to better recovery prognosis.Â
Clinical History
Gather information about prodromal, latent, illness phase, and recovery phase.Â
Physical Examination
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Symptoms for prodromal phase as:Â
Nausea/vomitingÂ
DiarrheaÂ
Fatigue/weaknessÂ
Symptoms for latent phase as:Â
InfectionsÂ
BleedingÂ
Symptoms for illness phaseÂ
LeukopeniaÂ
Bone Marrow SuppressionÂ
ThrombocytopeniaÂ
AnemiaÂ
Differential Diagnoses
Aplastic AnemiaÂ
Myelodysplastic SyndromesÂ
Acute LeukemiaÂ
SepsisÂ
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
Use granulocyte colony-stimulating factor to stimulate the production of neutrophils to reduce the duration of neutropenia.Â
Use granulocyte-macrophage colony-stimulating factor to stimulate white blood cell production.Â
Use prophylactic antibiotics to prevent bacterial infections in patients with neutropenia.Â
For patients at high risk of fungal infections use antifungals agent and  Â
for those at risk of viral infections use antivirals agent.Â
Red blood cell transfusions are indicated to manage symptomatic anemia.Â
Platelet transfusions are indicated to prevent bleeding in thrombocytopenia cases.Â
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
use-of-non-pharmacological-approach-for-hematopoietic-radiation-injury-syndrome
Isolate patients for protection and restrict access to minimize exposure.Â
Follow mandatory adherence to hand hygiene for healthcare providers and visitors.Â
Use HEPA filters to reduce airborne particles and lower infection risk efficiently.Â
Maintain ventilation in patient rooms for air quality control. Prepare food properly to prevent foodborne infections. Â
Create comfortable environment with temperature control, bedding, and pain management.Â
Proper awareness about HRIS should be provided and its related causes with management strategies.Â
Appointments with an oncologist and preventing recurrence of disorder is an ongoing life-long effort.Â
Use of Growth factors
It stimulates the production of neutrophils to help manage neutropenia.Â
Sargramostim:Â
It stimulates the production of white blood cells and supports overall hematopoiesis.Â
Use of Antifungal agent
Fluconazole:Â
It is used to prevent fungal infections in immunocompromised patients.Â
Use of Anti-nausea/vomiting Agents
Metoclopramide:Â Â
It is dopamine antagonist used to manage nausea and promote gastric motility.Â
use-of-intervention-with-a-procedure-in-treating-hematopoietic-radiation-injury-syndrome
Hematopoietic stem cell transplantation is considered in severe cases of bone marrow failure.Â
Blood product transfusions include red blood cell and platelet transfusions.Â
use-of-phases-in-hematopoietic-radiation-injury-syndrom
In the initial assessment phase, evaluation of medical history, laboratory test, radiation exposure, and patient symptoms to confirm diagnosis.Â
Pharmacologic therapy is effective in the treatment phase as it includes use of growth factor, antifungals, and anti-vomiting agents.Â
In supportive care and management phase, patients should receive required attention such as lifestyle modification and intervention therapies.Â
The regular follow-up visits with the oncologist are scheduled to check the improvement of patients along with treatment response.Â
Medication
Future Trends
Workers and responders with high radiation exposure had numerous cases of HRIS. Risk of HRIS from intentional radioactive material releases requires prevention.
Higher doses above 1 Gy leads to increased severity of HRIS. Acute exposure occurs in HRIS compared to chronic exposure.
Children and older adults more at risk from radiation due to weaker immune systems. A lack of strong evidence shows gender differences in HRIS susceptibility, with potential radiation sensitivity variations.
Workers and responders with high radiation exposure had numerous cases of HRIS. Risk of HRIS from intentional radioactive material releases requires prevention.Â
Higher doses above 1 Gy leads to increased severity of HRIS. Acute exposure occurs in HRIS compared to chronic exposure.Â
Children and older adults more at risk from radiation due to weaker immune systems. A lack of strong evidence shows gender differences in HRIS susceptibility, with potential radiation sensitivity variations.Â
Ionizing radiation causes DNA breaks in bone marrow stem and progenitor cells causes death and mutations.Â
Cells activate DNA damage response mechanisms cell cycle arrest, repair pathways, and apoptosis for irreparable damage.Â
Radiation affects hematopoietic stem cells proliferation and differentiation into blood cell lineages to reduce their function.Â
Growth factors such as G-CSF and erythropoietin stimulate hematopoietic stem cell proliferation and differentiation.Â
High-dose exposure results in severe HRIS, that increases mortality risk.Â
Children and elder individuals at higher risk due to weak immunity.Â
Medical intervention with growth factors, blood transfusions, and antibiotics improves outcomes.Â
Specialized medical facilities and expertise manage radiation injuries for prognosis.Â
Higher functional bone marrow post-exposure leads to better recovery prognosis.Â
Gather information about prodromal, latent, illness phase, and recovery phase.Â
Symptoms for prodromal phase as:Â
Nausea/vomitingÂ
DiarrheaÂ
Fatigue/weaknessÂ
Symptoms for latent phase as:Â
InfectionsÂ
BleedingÂ
Symptoms for illness phaseÂ
LeukopeniaÂ
Bone Marrow SuppressionÂ
ThrombocytopeniaÂ
AnemiaÂ
Aplastic AnemiaÂ
Myelodysplastic SyndromesÂ
Acute LeukemiaÂ
SepsisÂ
Use granulocyte colony-stimulating factor to stimulate the production of neutrophils to reduce the duration of neutropenia.Â
Use granulocyte-macrophage colony-stimulating factor to stimulate white blood cell production.Â
Use prophylactic antibiotics to prevent bacterial infections in patients with neutropenia.Â
For patients at high risk of fungal infections use antifungals agent and  Â
for those at risk of viral infections use antivirals agent.Â
Red blood cell transfusions are indicated to manage symptomatic anemia.Â
Platelet transfusions are indicated to prevent bleeding in thrombocytopenia cases.Â
Oncology, Other
Radiology
Isolate patients for protection and restrict access to minimize exposure.Â
Follow mandatory adherence to hand hygiene for healthcare providers and visitors.Â
Use HEPA filters to reduce airborne particles and lower infection risk efficiently.Â
Maintain ventilation in patient rooms for air quality control. Prepare food properly to prevent foodborne infections. Â
Create comfortable environment with temperature control, bedding, and pain management.Â
Proper awareness about HRIS should be provided and its related causes with management strategies.Â
Appointments with an oncologist and preventing recurrence of disorder is an ongoing life-long effort.Â
Oncology, Other
Radiology
It stimulates the production of neutrophils to help manage neutropenia.Â
Sargramostim:Â
It stimulates the production of white blood cells and supports overall hematopoiesis.Â
Oncology, Other
Radiology
Fluconazole:Â
It is used to prevent fungal infections in immunocompromised patients.Â
Oncology, Other
Radiology
Metoclopramide:Â Â
It is dopamine antagonist used to manage nausea and promote gastric motility.Â
Oncology, Other
Radiology
Hematopoietic stem cell transplantation is considered in severe cases of bone marrow failure.Â
Blood product transfusions include red blood cell and platelet transfusions.Â
Oncology, Other
Radiology
In the initial assessment phase, evaluation of medical history, laboratory test, radiation exposure, and patient symptoms to confirm diagnosis.Â
Pharmacologic therapy is effective in the treatment phase as it includes use of growth factor, antifungals, and anti-vomiting agents.Â
In supportive care and management phase, patients should receive required attention such as lifestyle modification and intervention therapies.Â
The regular follow-up visits with the oncologist are scheduled to check the improvement of patients along with treatment response.Â
Workers and responders with high radiation exposure had numerous cases of HRIS. Risk of HRIS from intentional radioactive material releases requires prevention.
Higher doses above 1 Gy leads to increased severity of HRIS. Acute exposure occurs in HRIS compared to chronic exposure.
Children and older adults more at risk from radiation due to weaker immune systems. A lack of strong evidence shows gender differences in HRIS susceptibility, with potential radiation sensitivity variations.
Workers and responders with high radiation exposure had numerous cases of HRIS. Risk of HRIS from intentional radioactive material releases requires prevention.Â
Higher doses above 1 Gy leads to increased severity of HRIS. Acute exposure occurs in HRIS compared to chronic exposure.Â
Children and older adults more at risk from radiation due to weaker immune systems. A lack of strong evidence shows gender differences in HRIS susceptibility, with potential radiation sensitivity variations.Â
Ionizing radiation causes DNA breaks in bone marrow stem and progenitor cells causes death and mutations.Â
Cells activate DNA damage response mechanisms cell cycle arrest, repair pathways, and apoptosis for irreparable damage.Â
Radiation affects hematopoietic stem cells proliferation and differentiation into blood cell lineages to reduce their function.Â
Growth factors such as G-CSF and erythropoietin stimulate hematopoietic stem cell proliferation and differentiation.Â
High-dose exposure results in severe HRIS, that increases mortality risk.Â
Children and elder individuals at higher risk due to weak immunity.Â
Medical intervention with growth factors, blood transfusions, and antibiotics improves outcomes.Â
Specialized medical facilities and expertise manage radiation injuries for prognosis.Â
Higher functional bone marrow post-exposure leads to better recovery prognosis.Â
Gather information about prodromal, latent, illness phase, and recovery phase.Â
Symptoms for prodromal phase as:Â
Nausea/vomitingÂ
DiarrheaÂ
Fatigue/weaknessÂ
Symptoms for latent phase as:Â
InfectionsÂ
BleedingÂ
Symptoms for illness phaseÂ
LeukopeniaÂ
Bone Marrow SuppressionÂ
ThrombocytopeniaÂ
AnemiaÂ
Aplastic AnemiaÂ
Myelodysplastic SyndromesÂ
Acute LeukemiaÂ
SepsisÂ
Use granulocyte colony-stimulating factor to stimulate the production of neutrophils to reduce the duration of neutropenia.Â
Use granulocyte-macrophage colony-stimulating factor to stimulate white blood cell production.Â
Use prophylactic antibiotics to prevent bacterial infections in patients with neutropenia.Â
For patients at high risk of fungal infections use antifungals agent and  Â
for those at risk of viral infections use antivirals agent.Â
Red blood cell transfusions are indicated to manage symptomatic anemia.Â
Platelet transfusions are indicated to prevent bleeding in thrombocytopenia cases.Â
Oncology, Other
Radiology
Isolate patients for protection and restrict access to minimize exposure.Â
Follow mandatory adherence to hand hygiene for healthcare providers and visitors.Â
Use HEPA filters to reduce airborne particles and lower infection risk efficiently.Â
Maintain ventilation in patient rooms for air quality control. Prepare food properly to prevent foodborne infections. Â
Create comfortable environment with temperature control, bedding, and pain management.Â
Proper awareness about HRIS should be provided and its related causes with management strategies.Â
Appointments with an oncologist and preventing recurrence of disorder is an ongoing life-long effort.Â
Oncology, Other
Radiology
It stimulates the production of neutrophils to help manage neutropenia.Â
Sargramostim:Â
It stimulates the production of white blood cells and supports overall hematopoiesis.Â
Oncology, Other
Radiology
Fluconazole:Â
It is used to prevent fungal infections in immunocompromised patients.Â
Oncology, Other
Radiology
Metoclopramide:Â Â
It is dopamine antagonist used to manage nausea and promote gastric motility.Â
Oncology, Other
Radiology
Hematopoietic stem cell transplantation is considered in severe cases of bone marrow failure.Â
Blood product transfusions include red blood cell and platelet transfusions.Â
Oncology, Other
Radiology
In the initial assessment phase, evaluation of medical history, laboratory test, radiation exposure, and patient symptoms to confirm diagnosis.Â
Pharmacologic therapy is effective in the treatment phase as it includes use of growth factor, antifungals, and anti-vomiting agents.Â
In supportive care and management phase, patients should receive required attention such as lifestyle modification and intervention therapies.Â
The regular follow-up visits with the oncologist are scheduled to check the improvement of patients along with treatment response.Â

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
